IDBS Recognized for Excellence in Biologics Digitalisation at ABEA 2026

IDBS Triumphs at the Asia Pacific Biopharma Excellence Awards 2026

IDBS, a prominent provider of cloud solutions tailored for biopharma companies and part of Danaher Corporation, has recently been honored with the Best Biologics Digitalisation Software Innovation Award at the prestigious Asia Pacific Biopharma Excellence Awards (ABEA) 2026. This accolade, presented on March 11th at the Sands Expo Convention Centre in Singapore, underscores IDBS's commitment to driving digital transformation within the biopharmaceutical landscape across the Asia-Pacific region.

The recognition reflects IDBS's significant impact on enhancing operational efficiencies, data quality, and scientific innovation in biologics development. As the industry continues to evolve, the need for effective digital tools becomes crucial. By winning this award, IDBS has reaffirmed its role as a leader in providing solutions that simplify complex processes and bolster scientific achievements in biopharma.

Pietro Forgione, General Manager at IDBS, expressed pride in receiving the award, stating, "This award is a tremendous honor for IDBS and a testament to the groundbreaking work our teams deliver globally. Biologics development is evolving rapidly, and our mission is to help organizations simplify complexity, accelerate scientific outcomes, and ensure the highest standards of quality and data integrity. Recognition from the biopharma community in the Asia-Pacific region reinforces the value our technology delivers to biopharma organizations worldwide."

The ABEA awards are designed to spotlight the advancements in biologics technology, recognizing those at the forefront of digital innovation. These awards specifically seek to celebrate technologies greatly enhancing development processes, addressing the increasing demand for rapid, quality drug development that the biopharmaceutical world necessitates today.

During the ceremony, which coincided with IMAPAC's Biologics World Asia conference, drawing together around 1,300 industry leaders from the region, IDBS showcased the strength and versatility of its cloud-based solutions. Among these are the widely recognized IDBS E-WorkBook software and IDBS Polar and PIMS cloud platforms, designed to facilitate intelligent decision-making and ensure compliance in both GxP and non-GxP settings.

The significance of this award not only lies in its acknowledgment of IDBS's contributions but also illustrates the evolving landscape of biopharma. With IDBS partnering with 80% of the top 20 global biopharma companies, its cloud solutions have become indispensable for a sector that is under constant pressure to innovate and comply with stringent regulatory standards. The successful implementation of AI and machine learning technologies within their platforms has allowed clients to gain insights that were previously unattainable, vastly improving patient outcomes.

As the biopharmaceutical industry shapes the future of healthcare, companies like IDBS will continue to leverage their expertise in scientific informatics to foster advances that benefit patients globally. Their commitment to excellence and use of cutting-edge technology positions them at the forefront of biopharma, and awards such as ABEA 2026 highlight the importance of collaboration between technology providers and biopharmaceutical organizations to meet the challenges of tomorrow.

To learn more about IDBS and their innovative offerings, visit idbs.com.